This statistic represents the amount of money the pharmaceutical industry in the U.S. had to pay in financial penalties from 1991 to 2017, by type of violation. Over this time the pharmaceutical industry paid some 1.8 billion U.S. dollars in financial penalties due to poor manufacturing practices in which they sold drug products that failed to meet FDA standards or specifications.
Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation
(in million U.S. dollars)
Characteristic
In million U.S. dollars
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
* Since the publication of the 2016 report, an additional federal, non-qui-tam settlement with Syncor, in 2002 for $2.5 million ($0.5 million civil penalty; $2 million criminal penalty) for kickbacks, was found and added to the database.
** Settlements that involved more than one type of violation were reviewed and, where possible, individual penalties for each type of violation were determined and added to the totals for that violation. The final total for “multiple violations” represents the sum total that could not be (or was not) attributed to a single violation.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Public Citizen. (March 14, 2018). Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation (in million U.S. dollars) [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/
Public Citizen. "Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation (in million U.S. dollars)." Chart. March 14, 2018. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/
Public Citizen. (2018). Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation (in million U.S. dollars). Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/
Public Citizen. "Pharmaceutical Industry Financial Penalties in The U.S. from 1991 to 2017, by Type of Violation (in Million U.S. Dollars)." Statista, Statista Inc., 14 Mar 2018, https://www.statista.com/statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/
Public Citizen, Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation (in million U.S. dollars) Statista, https://www.statista.com/statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/ (last visited July 22, 2024)
Pharmaceutical industry financial penalties in the U.S. from 1991 to 2017, by type of violation (in million U.S. dollars) [Graph], Public Citizen, March 14, 2018. [Online]. Available: https://www.statista.com/statistics/618850/us-pharmaceutical-industry-financial-penalties-by-violation-type/
